Market revenue in 2023 | USD 1.5 million |
Market revenue in 2030 | USD 8.9 million |
Growth rate | 28.6% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Kits & Reagents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Instruments, Services |
Key market players worldwide | Danaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to exosomes market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 46.67% in 2023. Horizon Databook has segmented the Spain exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in the number of research activities for exploring the potential of exosomes across various applications is expected to boost the exosomes market growth in the country. For instance, a research study was performed at Universidad Autónoma de Madrid in 2014, to determine the potential of exosomes to become a key target in the cardio-renal syndrome.
The study was performed across 23 hospitals in the country wherein researchers from the Barcelona Institute for Global Health (ISGlobal) and the Autonomous University of Madrid, Hospital la Princesa were employed.
The study concluded that stroke as well as ischaemic heart disease accounted for 22% of the total mortality rate in 2016; and ischaemic heart disease accounted for maximum deaths among other factors. Thus, research focused on utilization of exosomes in the cardiovascular disease application is expected to offer significant momentum to the Spain exosomes market.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain exosomes market , including forecasts for subscribers. This country databook contains high-level insights into Spain exosomes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account